Rendez-vous biannuel au Forum A3P
The purpose of this Event is to clarify the role of data integrity in current good manufacturing practice (CGMP) for drugs, as required in 21 CFR parts 210, 211, and 212. This Event provides the Agency’s current thinking on the creation and handling of data in accordance with CGMP requirements.
Forum A3P Suisse
eCompliance – Data Integrity
Lausanne (Aquatis Hotel) – 12 Mai 2016
Related posts